Drugs / QIVc
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01992107 | Nov 2013 → Aug 2014 | influenza | Novartis Vaccines | Completed | Met primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | QIVc | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01992107 ↗ |
| Modality | Vaccine | “mammalian cell-derived quadrivalent influenza vaccine (QIVc)” PMID 26585940 ↗ Nov 2015 |